
<http://bio2rdf.org/drugbank:DB00036> a <http://schema.org/Drug> ;
	<http://schema.org/name> "Coagulation factor VIIa" ;
	<http://schema.org/description> "Recombinant human coagulation Factor VIIa (rFVIIa), intended for promoting hemostasis by activating the extrinsic pathway of the coagulation cascade.1 NovoSeven is a vitamin K-dependent glycoprotein consisting of 406 amino acid residues. Cloned and expressed in hamster kidney cells, the protein is catalytically active in a two-chain form." ;
	<http://schema.org/drugClass> "Coagulants" , "Thrombotic Agents" ;
	<http://schema.org/url> "http://bio2rdf.org/drugbank:DB00036" ;
	<http://schema.org/clinicalPharmacology> "Used in the treatment of bleeding episodes in hemophilia A or B. NovoSeven is recombinant Factor VIIa and, when complexed with tissue factor can activate coagulation Factor X to Factor Xa, as well as coagulation Factor IX to Factor IXa. Factor Xa, in complex with other factors, then converts prothrombin to thrombin, which leads to the formation of a hemostatic plug by converting fibrinogen to fibrin and thereby inducing local clotting." ;
	<http://schema.org/cost> <http://bio2rdf.org/drugbank_resource:38fc3c8208901be296e311937c5d45cf> , <http://bio2rdf.org/drugbank_resource:69bd16fe5b0ec16f29338acc3dbe14ed> , <http://bio2rdf.org/drugbank_resource:e1569d089904646a682bc3ed991889ec> ;
	<http://schema.org/legalStatus> "Approved" ;
	<http://schema.org/mechanismOfAction> "NovoSeven activates the coagulation or clotting cascade by cleaving Factor IX and Factor X, which activates them and then leads to activation of thrombin and fibrin." ;
	<http://schema.org/nonProprietaryName> "Proconvertin" , "Coagulation factor VII precursor" , "Eptacog alfa" , "Serum prothrombin conversion accelerator" , "SPCA" ;
	<http://schema.org/proprietaryName> "NovoSeven" ;
	<http://schema.org/identifier> "drugbank:DB00036" ;
	<http://schema.org/sameAs> <http://www.rxlist.com/cgi/generic3/novoseven.htm> , <http://www.drugs.com/cdi/coagulation-factor-viia-recombinant.html> , <http://www.drugbank.ca/drugs/DB00036> .

<http://bio2rdf.org/drugbank_resource:38fc3c8208901be296e311937c5d45cf> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1.6399999856948852539" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Novoseven 2400 mcg vial" .

<http://bio2rdf.org/drugbank_resource:69bd16fe5b0ec16f29338acc3dbe14ed> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1.6399999856948852539" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Novoseven 4800 mcg vial" .

<http://bio2rdf.org/drugbank_resource:e1569d089904646a682bc3ed991889ec> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1.6399999856948852539" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Novoseven 1200 mcg vial" .
